Meet us at AACR 2025

We have a great line up of posters, booth demos, and an exciting new announcement planned for you this year!

Derisk ADC Development with AI Spatial Proteomics

ADCs hold great promise in oncology, but the complexity of tumor biology and the microenvironment presents a significant challenge for development.

Let’s explore how AI spatial proteomics can support your ADC program.

ADC Poster Session

AI-powered spatial inference platform for qualifying ADCs and multispecific therapeutic targets

ADC Booth Demos

See how you can leverage imaging and pathology data to map target distribution and heterogeneity, quantify the bystander effect, assess off-target toxicity and immunogenicity risk, and design biomarker-informed clinical trials

Hot-off-the-Press: We've Launched a First-of-its-Kind Deep Learning Model To Automate Spatial Proteomics Analysis

We’ve developed a new deep learning model that automates and standardizes a critical bottleneck in analyzing multiplex immunofluorescence (mIF) data. This brings us one step closer to discovering and validating spatial biomarkers across samples, different antibody markers, and across study cohorts. We’ll be sharing updates at AACR.

Additional Presentations

Immunotherapy Poster Session

Tumor microenvironment profiling of multiplexed images in head and neck cancer reveals spatial features associated with immunotherapy response

AACR Town Hall: AI Pathology in Cancer

How AI Will Impact the Future of Pathology: Now, Soon, and in the Future – A Pathology in Cancer Research Working Group Town Hall

Our AACR On-site Team

Avi Veidman

CEO

Dr. Ken Bloom

Head of Pathology

Jonathan Daniels

SVP Strategy & BD

Jason Reeves

Director, Application Science

Dr. Ettai Markovits

Director, Biomedical Research

Elad Amsalem

VP R&D

Book a demo or meeting with us

Please complete the form below to schedule a meeting with our team at AACR 2025:

Related Resources

Envisioning the Future of ADCs with AI Spatial Proteomics.
Intro to AI Spatial Biomarkers & Diagnostics for ADCs.
Using AI-Based Spatial Analysis to Explore Immunotherapy Biomarkers.